Biomerica INC (BMRA) — 10-Q Filings

10-Q Filings (6)

• Biomerica Posts Q1 Profit Amid Sales Dip, Going Concern Doubts Persist — Oct 14, 2025 Risk: high
  BIOMERICA INC (BMRA) reported a significant turnaround in net income for the three months ended August 31, 2025, achieving a net income of $2,000 compared to a
• Biomerica Inc. Files Q3 2025 10-Q Report — Apr 14, 2025 Risk: medium
  Biomerica Inc. filed its 10-Q for the period ending February 28, 2025. The company, previously known as NMS Pharmaceuticals Inc., is based in Irvine, CA, and op
• Biomerica Inc. Files Q2 FY2025 10-Q — Jan 14, 2025 Risk: medium
  Biomerica Inc. filed its 10-Q for the period ending November 30, 2024. The company reported financial results for the second quarter of fiscal year 2025. Specif
• Biomerica Inc. Files Q1 2025 10-Q — Oct 15, 2024 Risk: low
  Biomerica Inc. filed a 10-Q for the period ending August 31, 2024. The company, previously known as NMS Pharmaceuticals Inc., is involved in diagnostic substanc
• Biomerica Inc. Files 10-Q for Period Ending February 29, 2024 — Apr 12, 2024 Risk: low
  BIOMERICA INC (BMRA) filed a Quarterly Report (10-Q) with the SEC on April 12, 2024. Biomerica Inc. filed a 10-Q report for the period ending February 29, 2024.
• Biomerica Inc. Files 10-Q for Period Ending November 30, 2023 — Jan 16, 2024 Risk: low
  BIOMERICA INC (BMRA) filed a Quarterly Report (10-Q) with the SEC on January 16, 2024. Biomerica Inc. filed a 10-Q report for the period ending November 30, 202

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX